CD8A and neoplasm: Although an in-depth understanding of the regulation of tumor–host interactions has been underscored to optimize treatment strategies in immunotherapy, the role of circulating CD8+ T cells have not been extensively investigated in GC patients, especially in correlation to treatment response.